LinkedIn founder and venture capitalist Reid Hoffman has just launched drug discovery startup Manas AI, alongside Dr. Siddhartha Mukherjee, an oncologist.

Gilead Sciences, Inc.'s strong sales growth in Veklury, Livdelzi, and Trodelvy shows promise for long-term financial success.

The Royal Surrey Cancer Centre was reopened by two-time Paralympic gold medallist Erin Kennedy on Tuesday following a £6m ...

A Paralympic gold medallist has praised the support she recieved during her cancer diagnosis and treatment as she officially ...

The Allan Labor Government is backing Victoria's world-class cancer researchers, delivering $2.7 million to improve cancer outcomes and save lives ...

A national study seeking more effective treatment for deadly metaplastic breast cancer has identified two inhibitor drugs with the potential to ...

Anisa, 25, who is of Somali heritage, said her 'whole world stopped' when she was diagnosed - now she shares her story to ...

As our understanding of cancer has evolved, so too has the promise of personalized oncology — treatment tailored to each ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

The Lupus Therapeutics (LT) PALS Program: Empowering Lupus Patients Through Peer Advocacy and Clinical Trial Inclusion Lupus is a chronic autoimmune disease that disproportionately affects racial and ...

It's my pleasure today to be in conversation with Reid Hoffman, the co-founder of LinkedIn and the author of a new book, "Superagency: What Could Possibly Go Right With Our AI Future?" ...

We argue against selling Geron at current prices, citing strong market potential of imetelstat and Royalty Pharma deal ...